Navigation Links
DIA/AAPS Co-Sponsored Conference to Examine the Immunogenicity of Therapeutic Proteins
Date:7/30/2008

The Drug Information Association (DIA) and the American Association of Pharmaceutical Scientists (AAPS) will co-sponsor Immunogenicity of Therapeutic Proteins (September 10 -12; Bethesda, MD).

Horsham, PA (Vocus) July 30, 2008 -- The Drug Information Association (DIA) and the American Association of Pharmaceutical Scientists (AAPS) will co-sponsor http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16578&eventType=Meeting [Immunogenicity of Therapeutic Proteins] (September 10 -12; Bethesda, MD).

Discussion topics will include:

  • Current practices in immunogenicity evaluation
  • Role of preclinical assessment
  • Challenges of clinical immunogenicity assessment: case studies
  • Risk assessment and risk management
  • Regulatory perspectives
  • Future of immunogenicity assessment

“Industry practices in immunogenicity assessment are becoming more unified though challenges still exist in terms of technology and reduction to practice,” says Program Chair Steven J. Swanson, PhD, Executive Director, Medical Sciences, Clinical Immunology Department, Amgen, Inc. “This conference will review key aspects of assay development and validation as well as discuss challenges in implementation of these assays, data interpretation, and relevance to clinical outcomes.”

About the http://www.diahome.org/ [Drug Information Association (DIA)]:
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and internation
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2
...procedures are generally being fleased from patien...ne of California, observed a study at present whic...sary fertility procedures.// Lawrence Werlin,...gnosis (PGD) for three distinct groups of women. P...
...n pointed at reducing carbon monoxide emissions ha...onoxide can be fatal if inhaled and is involved in...ear. //The main sources of carbon monoxide are veh...talytic converters in cars helps bring down the ca...
...to researchers, it may be possible to increase the...shortage of organs for transplantation.// Research...ng at the supply of lungs for transplant. They not...hecked 30 pairs of lungs that had been rejected fo...
...to researchers in England, a baby's birth weight i...late adulthood. The study also shows women with th...risk of developing diabetes.// More than 4,10...ing among those with the highest insulin resistanc...
...rs at the Colulmbia University found that eating m...eloping Alzheimer's disease in some people. Previo...ricted diet tend to live longer. //Researchers fee...lso damage cells and may increase the damage done ...
...antioxidants have always been beneficial to our bo...tent is released from the grain, and thereby makin...e has always been a common misconception that boil...ou may well gain more antioxidant power than you l...
Other Medicine News:Health News:Diet combined to Alzheimer's disease 2
(Date:12/4/2009)FREMONT, Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, 2009, it filed its First Amended Plan of Reorganization and related amended Disclosure Statement wit
(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Amber Pharmacy Earns Accreditation From ACHC 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 1Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 2Narconon of Georgia Applauds Efforts of Prescription Buy Back Programs 5577 1Narconon of Georgia Applauds Efforts of Prescription Buy Back Programs 5577 2Researcher honored for experimental work in nanotechnology 14533 1Researcher honored for experimental work in nanotechnology 14533 2
... April 11, 2007 (PRIME NEWSWIRE) --,Hana Bioscienc...sed,on advancing cancer care, will present preclin...ion at the American Association,for Cancer Researc...geles, California. , Abstract No. 2210: "Combining...mall cell lung cancer (NSCLC) athymic nude,mice xe...
...onex Inc. (TSX:LPX), a,biopharmaceutical company s...d to High Density Lipoprotein (HDL), often called,...om further,analysis of the Phase I/II Clinical Tri...ped for the treatment of dyslipidemia and,heart di...indicated that all,blood chemistry and blood press...
Other Medicine Technology:Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 2Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 3
... Clear Plus™ Uncuffed Endotracheal Tube w. F...et inside. Sterile, Single use. A quality Rusch en... is ready to use saving you time and storage space...ate smooth withdrawal. It is designed with a soft ...
Slick Set® Uncuffed
Cuffed Nasoral Magill
...ubber tube with Murphy eye. Laser resistant foam s...uffs (One inside other) 40cm (16") long, Single Us...access and optimum visibility within the operating...he tube shaft has a special laser-guard of approx....
Medicine Products: